OBJECTIVE: The purpose of this study was to compare outcomes after sacrocolpopexy (SC) between obese and healthy-weight women. STUDY DESIGN: Baseline and postoperative data were analyzed from the Colpopexy And Urinary Reduction Efforts (CARE) randomized trial of SC with or without Burch colposuspension in stress continent women with stages II-IV prolapse. Outcomes and complications were compared between obese and healthy-weight women. RESULTS:CARE participants included 74 obese (body mass index >/=30 kg/m(2)), 122 overweight (25-29.9 kg/m(2)), and 125 healthy-weight (18.5-24.9 kg/m(2)) women, and 1 underweight (< 18.5 kg/m(2)) woman. Compared to healthy-weight women, obese women were younger (59.0 +/- 9.9 vs 62.1 +/- 10.3 yrs; P = .04), more likely to have stage II prolapse (25.7% vs 11.2%; P = .01), and had longer operative times (189 +/- 52 vs 169 +/- 58 min; P = .02). Two years after surgery, stress incontinence, prolapse, symptom resolution, and satisfaction did not differ between the obese and healthy-weight groups. CONCLUSION: Most outcomes and complication rates after SC are similar in obese and healthy-weight women.
RCT Entities:
OBJECTIVE: The purpose of this study was to compare outcomes after sacrocolpopexy (SC) between obese and healthy-weight women. STUDY DESIGN: Baseline and postoperative data were analyzed from the Colpopexy And Urinary Reduction Efforts (CARE) randomized trial of SC with or without Burch colposuspension in stress continent women with stages II-IV prolapse. Outcomes and complications were compared between obese and healthy-weight women. RESULTS: CARE participants included 74 obese (body mass index >/=30 kg/m(2)), 122 overweight (25-29.9 kg/m(2)), and 125 healthy-weight (18.5-24.9 kg/m(2)) women, and 1 underweight (< 18.5 kg/m(2)) woman. Compared to healthy-weight women, obesewomen were younger (59.0 +/- 9.9 vs 62.1 +/- 10.3 yrs; P = .04), more likely to have stage II prolapse (25.7% vs 11.2%; P = .01), and had longer operative times (189 +/- 52 vs 169 +/- 58 min; P = .02). Two years after surgery, stress incontinence, prolapse, symptom resolution, and satisfaction did not differ between the obese and healthy-weight groups. CONCLUSION: Most outcomes and complication rates after SC are similar in obese and healthy-weight women.
Authors: Patricia A Wren; Nancy K Janz; Linda Brubaker; Mary Pat Fitzgerald; Anne M Weber; Frankie B LaPorte; John T Wei Journal: Am J Obstet Gynecol Date: 2005-03 Impact factor: 8.661
Authors: Yoram Abramov; Peter K Sand; Sylvia M Botros; Sanjay Gandhi; Jay-James R Miller; Angel Nickolov; Roger P Goldberg Journal: Obstet Gynecol Date: 2005-10 Impact factor: 7.661
Authors: Holly E Richter; Kathryn L Burgio; Linda Brubaker; Pamela A Moalli; Alayne D Markland; Veronica Mallet; Shawn A Menefee; Harry W Johnson; Muriel K Boreham; Kimberly J Dandreo; Anne M Stoddard Journal: Am J Obstet Gynecol Date: 2005-12 Impact factor: 8.661
Authors: R G Rogers; U Lebküchner; D N Kammerer-Doak; P K Thompson; M D Walters; I E Nygaard Journal: Am J Obstet Gynecol Date: 2006-10-02 Impact factor: 8.661
Authors: Linda Brubaker; Geoffrey W Cundiff; Paul Fine; Ingrid Nygaard; Holly E Richter; Anthony G Visco; Halina Zyczynski; Morton B Brown; Anne M Weber Journal: N Engl J Med Date: 2006-04-13 Impact factor: 91.245
Authors: Brian J Linder; George K Chow; Lindsay L Hertzig; Marisa Clifton; Daniel S Elliott Journal: Int Braz J Urol Date: 2015 Mar-Apr Impact factor: 1.541
Authors: Antoine Tshimbundu Kayembe; Charles Didier Kitenge Kia Kayembe; Jean-Patrick Kamba Bebele; Rahma Rachid Tozin Journal: Pan Afr Med J Date: 2021-12-16